Baroreflex activation therapy in heart failure patients with reduced ejection fraction: a long-term follow up

被引：0
作者：
Wang, D. [1 ]
Mueller-Leisse, J. [1 ]
Hillmann, H. A. K. [1 ]
Eiringhaus, J. [1 ]
Berliner, D. [1 ]
Karfoul, N. [1 ]
Schmitto, J. D. [2 ]
Ruhparwar, A. [2 ]
Bauersachs, J. [1 ]
Duncker, D. [1 ]
机构：
[1] Hannover Med Sch, Cardiol & Angiol, Hannover, Germany
[2] Hannover Med Sch, Cardiothorac Transplantat & Vasc Surg, Hannover, Germany
来源：
EUROPEAN HEART JOURNAL | 2024年 / 45卷
关键词：
D O I：
10.1093/eurheartj/ehae666.1141
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Long-Term Functional and Clinical Follow-Up of Patients With Heart Failure With Recovered Left Ventricular Ejection Fraction After β-Blocker Therapy
    de Groote, Pascal
    Fertin, Marie
    Pentiah, Anju Duva
    Goeminne, Celine
    Lamblin, Nicolas
    Bauters, Christophe
    CIRCULATION-HEART FAILURE, 2014, 7 (03) : 434 - U88
  • [42] SIMULATING BAROREFLEX ACTIVATION THERAPY FOR THE TREATMENT OF HEART FAILURE WITH PRESERVED EJECTION FRACTION
    Clemmer, John S.
    Pruett, W. Andrew
    Hester, Robert L.
    PROCEEDINGS OF THE 2022 DESIGN OF MEDICAL DEVICES CONFERENCE (DMD2022), 2022,
  • [43] Consequences of Discontinuing Long-Term Drug Treatment in Patients With Heart Failure and Reduced Ejection Fraction
    Talha, Khawaja M.
    Butler, Javed
    Packer, Milton
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 84 (22) : 2215 - 2232
  • [44] IMPROVED EXERCISE EJECTION FRACTION WITH LONG-TERM PRAZOSIN THERAPY IN PATIENTS WITH HEART-FAILURE
    GOLDMAN, SA
    JOHNSON, LL
    ESCALA, E
    CANNON, PJ
    WEISS, MB
    AMERICAN JOURNAL OF MEDICINE, 1980, 68 (01) : 36 - 42
  • [45] Positive effects of baroreflex activation therapy in heart failure with reduced ejection fraction are independent of baseline blood pressure
    Wachter, R.
    Abraham, W. T.
    Lindenfeld, J.
    Weaver, F. A.
    Zannad, F.
    Wilks, S.
    Schafer, J. E.
    Zile, M. R.
    EUROPEAN HEART JOURNAL, 2017, 38 : 301 - 301
  • [46] Baroreflex activation therapy for heart failure with reduced ejection fraction: A comprehensive systematic review and meta-analysis
    Shi, Ruijie
    Sun, Tong
    Wang, Mengxi
    Xiang, Qian
    Ding, Yuhan
    Yin, Siyuan
    Chen, Yan
    Shen, Le
    Yu, Peng
    Chen, Xiaohu
    HELIYON, 2024, 10 (02)
  • [47] Tolvaptan Improves the Long-Term Prognosis in Patients With Congestive Heart Failure With Preserved Ejection Fraction as Well as in Those With Reduced Ejection Fraction
    Imamura, Teruhiko
    Kinugawa, Koichiro
    INTERNATIONAL HEART JOURNAL, 2016, 57 (05) : 600 - 606
  • [48] Clinical Characteristics and Long-term Prognosis in Patients with Chronic Heart Failure and Reduced Ejection Fraction in China
    Liu, Xiaoyan
    Yu, Haiyun
    Pei, Juanhui
    Chu, Jianmin
    Pu, Jielin
    Zhang, Shu
    HEART LUNG AND CIRCULATION, 2014, 23 (09) : 818 - 826
  • [49] Clinical predictors of the long-term progression of renal dysfunction in heart failure patients with reduced ejection fraction
    Ural, D. Dilek
    Argan, O.
    Karauzum, K.
    Karauzum, I.
    Kozdag, G.
    Agir, A.
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 250 - 250
  • [50] Left atrial reservoir strain and long-term prognosis in patients with heart failure and reduced ejection fraction
    Chimed, S.
    Stassen, J.
    Galloo, X.
    Meucci, M. C.
    Van der Bijl, P.
    Marsan, N. A.
    Delgado, V.
    Bax, J. J.
    EUROPEAN HEART JOURNAL, 2022, 43 : 926 - 926
12345